Quick Answer
Altimmune, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $4.41 million for the year ending 2021.
- Altimmune, Inc. showed a decrease of -46.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2020 to 2021.
- This data is from Altimmune, Inc.'s annual report (Form 10-K), filed with the SEC on March 15, 2022.
- XBRL data for this metric is available from 2017 to 2021 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2017 to 2021), Altimmune, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 58.9%.
- Historical annual values: Fiscal year 2021: $4.41 million | Fiscal year 2020: $8.19 million | Fiscal year 2019: $5.80 million | Fiscal year 2018: $10.33 million | Fiscal year 2017: $10.74 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: